The senescence-accelerated mouse prone 8 (SAMP8) strain is considered a robust experimental model for developing preventative and therapeutic treatments for Alzheimer’s disease (AD), a neurodegenerative disease which cannot be effectively prevented, halted, or cured. Our previous studies showed that LW-AFC, a new formula derived from the classical traditional Chinese medicinal prescription Liuwei Dihuang decoction, ameliorates cognitive deterioration in PrP-hAβPPswe/PS1ΔE9 transgenic mice and SAMP8 mice. This study aims to investigate the mechanism that mediates how LW-AFC improves cognitive deficit on the basis of the transcriptome. We conducted a genome-wide survey of gene expression in the hippocampus in mice from the senescence accelerated mouse resistant 1 (SAMR1) strain, from SAMP8 and from LW-AFC treated SAMP8. The results showed that LW-AFC reversed the transcriptome in the hippocampus of SAMP8 mice. The specific investigation of altered gene expression in subtypes defined by cognitive profiles indicated that the systemic lupus erythematosus pathway, spliceosomes, amyotrophic lateral sclerosis, and the insulin signaling were involved in the improvement of cognitive ability by LW-AFC. The expression of genes Enpp2, Etnk1, Epdr1, and Gm5900 in the hippocampus were correlated with that of LW-AFC’s ameliorating cognitive impairment in SAMP8 mice. Because LW-AFC is composed of polysaccharides, glycosides, and oligosaccharides, we infer that LW-AFC has direct or indirect effects on altering gene expressions and regulating pathways in the hippocampus of SAMP8 mice. These data are helpful for the enhanced identification of LW-AFC as new therapeutic modalities to AD.
PallásM (2012) Senescence-accelerated mice P8: A tool to study brain aging and Alzheimer’s disease in a mouse model. ISRN Cell Biol2012, 1–12.
2.
MorleyJE, ArmbrechtHJ, FarrSA, KumarVB (2012) The senescence accelerated mouse (SAMP8) as a model for oxidative stress and Alzheimer’s disease. Biochim Biophys Acta1822, 650–656.
3.
PallasM, CaminsA, SmithMA, PerryG, LeeHG, CasadesusG (2008) From aging to Alzheimer’s disease: Unveiling “the switch” with the senescence-accelerated mouse model (SAMP8). J Alzheimers Dis15, 615–624.
4.
ChengXR, ZhouWX, ZhangYX (2014) The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer’s disease animal model. Ageing Res Rev13, 13–37.
5.
WangJ, LeiX, ChengX, ZhangX, LiuG, ChengJ, XuY, ZengJ, ZhouW, ZhangY (2017) LW-AFC, a new formula derived from Liuwei Dihuang decoction, ameliorates behavioral and pathological deterioration via modulating the neuroendocrine-immune system in PrP-hAβPPswe/PS1ΔE9 transgenic mice. Alzheimers Res Ther8, 57.
6.
WangJ, ZhangX, ChengX, ChengJ, LiuF, XuY, ZengJ, QiaoS, ZhouW, ZhangY (2017) LW-AFC, a herbal medicine for Alzheimer’s disease, ameliorates cognitive deterioration and modulates neuroendocrine-immune system in senescence-accelerated mouse prone 8 strain. Curr Alzheimer Res14, 18.
7.
WangJ, YeF, ChengX, ZhangX, LiuF, LiuG, NiM, QiaoS, ZhouW, ZhangY (2016) The effects of LW-AFC on intestinal microbiome in senescence-accelerated mouse prone 8 strain, a mouse model of Alzheimer’s disease. J Alzheimers Dis53, 907–919.
8.
WangJ, ChengX, ZengJ, YuanJ, WangZ, ZhouW, ZhangY (2017) LW-AFC effects on N-glycan profile in senescence-accelerated mouse prone 8 strain, a mouse model of Alzheimer’s disease. Aging Dis8, 14.
9.
WangJ, ChengX, ZhangX, ChengJ, XuY, ZengJ, ZhouW, ZhangY (2016) The anti-aging effects of LW-AFC via correcting immune dysfunctions in senescence accelerated mouse resistant 1 (SAMR1) strain. Oncotarget7, 26949–26965.
10.
ZhangB, HorvathS (2005) A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol4, Article 17.
11.
TrapnellC, RobertsA, GoffL, PerteaG, KimD, KelleyDR, PimentelH, SalzbergSL, RinnJL, PachterL (2012) Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc7, 562–578.
12.
SubramanianA, TamayoP, MoothaVK, MukherjeeS, EbertBL, GilletteMA, PaulovichA, PomeroySL, GolubTR, LanderES, MesirovJP (2005) Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A102, 15545–15550.
13.
AshburnerM, BallCA, BlakeJA, BotsteinD, ButlerH, CherryJM, DavisAP, DolinskiK, DwightSS, EppigJT, HarrisMA, HillDP, Issel-TarverL, KasarskisA, LewisS, MateseJC, RichardsonJE, RingwaldM, RubinGM, SherlockG (2000) Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat Genet25, 25–29.
14.
KanehisaM, SatoY, KawashimaM, FurumichiM, TanabeM (2016) KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res44, D457–D462.
15.
Huangda W, ShermanBT, LempickiRA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc4, 44–57.
16.
EppigJT, BlakeJA, BultCJ, KadinJA, RichardsonJE, Mouse Genome Database Group (2015) The Mouse Genome Database (MGD): Facilitating mouse as a model for human biology and disease. Nucleic Acids Res43, D726–D736.
17.
ChengXR, ZhouWX, ZhangYX, ZhouDS, YangRF, ChenLF (2007) Differential gene expression profiles in the hippocampus of senescence-accelerated mouse. Neurobiol Aging28, 497–506.
18.
KumarVB, FrankoMP, FarrSA, ArmbrechtHJ, MorleyJE (2000) Identification of age-dependent changes in expression of senescence-accelerated mouse (SAMP8) hippocampal proteins by expression array analysis. Biochem Biophys Res Commun272, 657–661.
GalvinJE, GinsbergSD (2005) Expression profiling in the aging brain: Aerspective. Ageing Res Rev4, 529–547.
21.
ChengXR, CuiXL, ZhengY, ZhangGR, LiP, HuangH, ZhaoYY, BoXC, WangSQ, ZhouWX, ZhangYX (2013) Nodes and biological processes identified on the basis of network analysis in the brain of the senescence accelerated mice as an Alzheimer’s disease animal model. Front Aging Neurosci5, 19.
22.
van MeeterenLA, MoolenaarWH (2007) Regulation and biological activities of the autotaxin-LPA axis. Prog Lipid Res46, 145–160.
23.
MillsGB, MoolenaarWH (2003) The emerging role of lysophosphatidic acid in cancer. Nat Rev Cancer3, 582–591.
GeachTJ, FaasL, DevaderC, Gonzalez-CorderoA, TablerJM, BrunsdonH, IsaacsHV, DaleL (2014) An essential role for LPA signalling in telencephalon development. Development141, 940–949.
Gregorio-KingCC, McLeodJL, CollierFM, CollierGR, BoltonKA, Van Der MeerGJ, ApostolopoulosJ, KirklandMA (2002) MERP1: A mammalian ependymin-related protein gene differentially expressed in hematopoietic cells. Gene286, 249–257.
34.
FrittoliRB, de Oliveira PelicariK, BelliniBS, MariniR, FernandesPT, AppenzellerS (2016) Association between academic performance and cognitive dysfunction in patients with juvenile systemic lupus erythematosus. Rev Bras Reumatol (Rio J)56, 252–257.
35.
TaySH, MakA (2015) Anti-NR2A/B antibodies and other major molecular mechanisms in the pathogenesis of cognitive dysfunction in systemic lupus erythematosus. Int J Mol Sci16, 10281–10300.
36.
TaySH, HoCS, HoRC, MakA (2015) 25-hydroxyvitamin D3 deficiency independently predicts cognitive impairment in patients with systemic lupus erythematosus. PLoS One10, e0144149.
37.
CesarB, DwyerMG, ShucardJL, PolakP, BergslandN, BenedictRH, Weinstock-GuttmanB, ShucardDW, ZivadinovR (2015) Cognitive and white matter tract differences in ms and diffuse neuropsychiatric systemic lupus erythematosus. AJNR Am J Neuroradiol36, 1874–1883.
38.
HanlyJG (2014) Diagnosis and management of neuropsychiatric SLE. Nat Rev Rheumatol10, 338–347.
WahlMC, LuhrmannR (2015) SnapShot: Spliceosome dynamics I. Cell161, 1474–e1471.
41.
PapasaikasP, ValcarcelJ (2016) The spliceosome: The ultimate RNA chaperone and sculptor. Trends Biochem Sci41, 33–45.
42.
SchutzeT, UlrichAK, ApeltL, WillCL, BartlickN, SeegerM, WeberG, LuhrmannR, StelzlU, WahlMC (2016) Multiple protein-protein interactions converging on the Prp38 protein during activation of the human spliceosome. RNA22, 265–277.
43.
TianJ, LiuY, ZhuB, TianY, ZhongR, ChenW, LuX, ZouL, ShenN, QianJ, LiH, MiaoX, WangL (2015) SF3A1 and pancreatic cancer: New evidence for the association of the spliceosome and cancer. Oncotarget6, 37750–37757.
44.
StarkMR, DunnEA, DunnWS, GrisdaleCJ, DanieleAR, HalsteadMR, FastNM, RaderSD (2015) Dramatically reduced spliceosome in Cyanidioschyzon merolae. Proc Natl Acad Sci U S A112, E1191–E1200.
45.
TresiniM, WarmerdamDO, KolovosP, SnijderL, VrouweMG, DemmersJA, vanIWF, GrosveldFG, MedemaRH, HoeijmakersJH, MullendersLH, VermeulenW, MarteijnJA (2015) The core spliceosome as target and effector of non-canonical ATM signalling. Nature523, 53–58.
46.
SpalloniA, LongoneP (2016) Cognitive impairment in amyotrophic lateral sclerosis, clues from the SOD1 mouse. Neurosci Biobehav Rev60, 12–25.
47.
ConsonniM, CatricalaE, Dalla BellaE, GessaVC, LauriaG, CappaSF (2016) Beyond the consensus criteria: Multiple cognitive profiles in amyotrophic lateral sclerosis?Cortex81, 162–167.
48.
YeS, JiY, LiC, HeJ, LiuX, FanD (2016) The Edinburgh Cognitive and Behavioural ALS screen in a Chinese amyotrophic lateral sclerosis population. PLoS One11, e0155496.
49.
van der HulstEJ, BakTH, AbrahamsS (2015) Impaired affective and cognitive theory of mind and behavioural change in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry86, 1208–1215.
50.
ChambersDB, AndroschukA, RosenfeltC, LangerS, HardingM, BolducFV (2015) Insulin signaling is acutely required for long-term memory in Drosophila. Front Neural Circuits9, 8.
51.
TakachO, GillTB, SilvermanMA (2015) Modulation of insulin signaling rescues BDNF transport defects independent of tau in amyloid-beta oligomer-treated hippocampal neurons. Neurobiol Aging36, 1378–1382.
52.
GontierG, GeorgeC, ChakerZ, HolzenbergerM, AidS (2015) Blocking IGF signaling in adult neurons alleviates Alzheimer’s disease pathology through amyloid-beta clearance. J Neurosci35, 11500–11513.
53.
van ExelE, EikelenboomP, ComijsH, DeegDJ, StekML, WestendorpRG (2014) Insulin-like growth factor-1 and risk of late-onset Alzheimer’s disease: Findings from a family study. Neurobiol Aging35, 725e727–710.
54.
TalbotK, WangHY (2014) The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer’s disease. Alzheimers Dement10, S12–S25.
55.
De FeliceFG, VieiraMN, BomfimTR, DeckerH, VelascoPT, LambertMP, ViolaKL, ZhaoWQ, FerreiraST, KleinWL (2009) Protection of synapses against Alzheimer’s-linked toxins: Insulin signaling prevents the pathogenic binding of Abeta oligomers. Proc Natl Acad Sci U S A106, 1971–1976.
56.
CraftS (2012) Alzheimer disease: Insulin resistance and AD–extending the translational path. Nat Rev Neurol8, 360–362.
57.
RozingMP, WestendorpRG, FrolichM, de CraenAJ, BeekmanM, HeijmansBT, MooijaartSP, BlauwGJ, SlagboomPE, van HeemstD, Leiden Longevity Study Group (2009) Human insulin/IGF-1 and familial longevity at middle age. Aging (Albany NY)1, 714–722.
58.
TaoJH, ZhaoM, WangDG, YangC, DuLY, QiuWQ, JiangS (2016) Biotransformation and metabolic profile of catalpol with human intestinal microflora by ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci1009-1010, 163–169.
59.
XueB, MaB, ZhangQ, LiX, ZhuJ, LiuM, WuX, WangC, WuZ (2015) Pharmacokinetics and tissue distribution of Aucubin, Ajugol and Catalpol in rats using a validated simultaneous LC-ESI-MS/MS assay. J Chromatogr B Analyt Technol Biomed Life Sci1002, 245–253.
60.
WangFY, LvWS, HanL (2015) Determination and pharmacokinetic study of pachymic acid by LC-MS/MS. Biol Pharm Bull38, 1337–1344.
61.
ShengN, ZhiX, YuanL, ZhangZ, JiaP, ZhangX, ZhangL, WangX (2014) Pharmacokinetic and excretion study of three secoiridoid glycosides and three flavonoid glycosides in rat by LC-MS/MS after oral administration of the Swertia pseudochinensis extract. J Chromatogr B Analyt Technol Biomed Life Sci967, 75-83.
62.
ShengN, YuanL, ZhiX, CuiC, ZhangZ, JiaP, ZhangX, ZhangL, WangX (2014) Application of a liquid chromatography-tandem mass spectrometry method to the pharmacokinetics, tissue distribution and excretion studies of sweroside in rats. J Chromatogr B Analyt Technol Biomed Life Sci969, 1–11.
63.
LeeKH, HoWY, WuSJ, OmarHA, HuangPJ, WangCC, HungJH (2014) Modulation of cyclins, p53 and mitogen-activated protein kinases signaling in breast cancer cell lines by 4-(3,4,5-trimethoxyphenoxy)benzoic acid. Int J Mol Sci15, 743–757.
64.
WuYT, TsaiTR, LinLC, TsaiTH (2007) Liquid chromatographic method with amperometric detection to determine acteoside in rat blood and brain microdialysates and its application to pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci853, 281–286.
